| 801 | ZNTLZentalis Pharmaceuticals, Inc. |
US$ 0 |
n/d |
2025 |
| 802 | SABSSAB Biotherapeutics, Inc. |
US$ 0 |
n/d |
2025 |
| 803 | FULCFulcrum Therapeutics, Inc. |
US$ 0 |
n/d |
2025 |
| 804 | NKTXNkarta, Inc. |
US$ 0 |
n/d |
2025 |
| 805 | MOLNMolecular Partners AG |
CHF 0 |
n/d |
2025 |
| 806 | SPRBSpruce Biosciences, Inc. |
US$ 0 |
n/d |
2025 |
| 807 | AARDAardvark Therapeutics, Inc. |
US$ 0 |
n/d |
2025 |
| 808 | HURATuHURA Biosciences, Inc. |
US$ 0 |
n/d |
2025 |
| 809 | VTVTvTv Therapeutics Inc. |
US$ 0 |
n/d |
2025 |
| 810 | VANIVivani Medical, Inc. |
US$ 0 |
n/d |
2025 |
| 811 | GUTSFractyl Health, Inc. |
US$ 0 |
n/d |
2025 |
| 812 | ELOXEloxx Pharmaceuticals, Inc. |
US$ 0 |
n/d |
2025 |
| 813 | ANVSAnnovis Bio, Inc. |
US$ 0 |
n/d |
2025 |
| 814 | RNTXRein Therapeutics, Inc. |
US$ 0 |
n/d |
2025 |
| 815 | APLMApollomics Inc. |
US$ 0 |
n/d |
2024 |
| 816 | PLRXPliant Therapeutics, Inc. |
US$ 0 |
n/d |
2025 |
| 817 | TENXTenax Therapeutics, Inc. |
US$ 0 |
n/d |
2025 |
| 818 | IXHLIncannex Healthcare Inc. |
US$ 0 |
n/d |
2026 |
| 819 | NNVCNanoviricides, Inc. |
US$ 0 |
n/d |
2025 |
| 820 | LITSLite Strategy, Inc. |
US$ 0 |
n/d |
2025 |
| 821 | BYSIBeyondSpring Inc. |
US$ 0 |
n/d |
2025 |
| 822 | BRNSBarinthus Biotherapeutics plc. |
US$ 0 |
n/d |
2025 |
| 823 | PTNPalatin Technologies Inc |
US$ 0 |
n/d |
2025 |
| 824 | KALAKALA BIO, Inc. |
US$ 0 |
n/d |
2025 |
| 825 | ADGMAdagio Medical Holdings, Inc. |
US$ 0 |
n/d |
2025 |
| 826 | BCDABioCardia, Inc. |
US$ 0 |
n/d |
2025 |
| 827 | MBRXMoleculin Biotech, Inc. |
US$ 0 |
n/d |
2025 |
| 828 | KPRXKiora Pharmaceuticals Inc |
US$ 0 |
n/d |
2025 |
| 829 | XCURExicure, Inc. |
US$ 0 |
n/d |
2025 |
| 830 | AZTRAzitra, Inc. |
US$ 0 |
n/d |
2025 |
| 831 | AMIXAutonomix Medical, Inc. |
US$ 0 |
n/d |
2026 |
| 832 | PMCBPharmaCyte Biotech, Inc. |
US$ 0 |
n/d |
2026 |
| 833 | APTOFAptose Biosciences Inc. |
US$ 0 |
n/d |
2025 |
| 834 | BZYRBurzynski Research Institute Inc |
US$ 0 |
n/d |
2025 |
| 835 | CNBXCNBX Pharmaceuticals Inc. |
US$ 0 |
n/d |
2025 |
| 836 | EDGMEdgemode, Inc. |
US$ 0 |
n/d |
2025 |
| 837 | GIPLGlobal Innovative Platforms Inc. |
US$ 0 |
n/d |
2025 |
| 838 | HSTCHST Global, Inc. |
US$ 0 |
n/d |
2023 |
| 839 | PTIXProtagenic Therapeutics, Inc. |
US$ 0 |
n/d |
2026 |
| 840 | BIOMSB Technology Holdings, Inc. |
US$ 0 |
n/d |
2014 |
| 841 | SYBXSynlogic, Inc. |
US$ 0 |
n/d |
2025 |
| 842 | UEECUnited Health Products, Inc. |
US$ 0 |
n/d |
2025 |
| 843 | NVSNovartis AG |
n/d |
n/d |
2025 |
| 844 | SNYSanofi |
n/d |
n/d |
2025 |
| 845 | ARGXArgenx SE |
n/d |
n/d |
2025 |
| 846 | FMSFresenius Medical Care AG |
n/d |
n/d |
2016 |
| 847 | ABVXAbivax S.A. |
n/d |
n/d |
2025 |
| 848 | SMMTSummit Therapeutics Inc. |
n/d |
n/d |
2025 |
| 849 | APGEApogee Therapeutics, Inc. |
n/d |
n/d |
2025 |
| 850 | IMVTImmunovant, Inc. |
n/d |
n/d |
2026 |